Tumor Board: Bridging Current Practices and New Therapeutic Developments in ER-Positive Breast Cancer

During this educational Tumor Board, breast cancer specialists will showcase challenging scenarios in metastatic and non-metastatic HR+ disease and contextualize data from pivotal clinical trials to optimize decision-making for patients with HR+/HER2- breast cancer.

Featuring: 
Fátima Cardoso, MD

Director, Breast Unit

Champalimaud Clinical Center

Lisbon, Portugal

Chief Executive Officer

Institut de Cancérologie de l’Ouest (ICO)

Angers, France

Chairman

Department of Pathology

University of Milan

Milan, Italy